drugset / Trial / NCT01684423
Oral Rivaroxaban in Children With Venous Thrombosis
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to find out whether rivaroxaban is safe to use in children and how long it stays in the body. There will also be a check for bleeding and worsening of blood clots.
Timeline
- Start
- 2013-02-19
- Primary completion
- 2016-09-01
- Completion
- 2016-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Rivaroxaban | Other / unclassified | 5 mg | Oral |
| Subject | Rivaroxaban | Other / unclassified | 6.4 mg | Oral |
| Subject | Rivaroxaban | Other / unclassified | 15 mg | Oral |
| Subject | Rivaroxaban | Other / unclassified | 20 mg | Oral |